Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer vaccines. Part 2

P A Hallin1, V R Adams

  • 1M.D. Anderson Cancer Center, Houston, Tex., USA.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|January 13, 1998
PubMed
Summary

Cancer vaccines show promise for immune modulation and antitumor effects, with ongoing trials exploring their use alongside traditional therapies. Future integration into pharmacy practice for patient counseling and administration is anticipated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2004
Same author

Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.

Bone marrow transplantation·2004
Same author

Antiangiogenesis agents in clinical trials.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2002
Same author

Computerized system for outcomes-based antiemetic therapy in children.

The Annals of pharmacotherapy·2000
Same author

Adverse events associated with chemotherapy for common cancers.

Pharmacotherapy·2000
Same author

Interactive discussion on chemotherapy-related adverse events.

Pharmacotherapy·2000

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Cancer vaccines are under extensive investigation for their potential to modulate the immune system and induce antitumor responses.
  • Current research explores vaccines as a complementary cancer therapy alongside chemotherapy, surgery, and radiation.
  • While widespread approval is pending, cancer vaccines represent a rapidly advancing frontier in oncology.

Purpose of the Study:

  • To review the current landscape of cancer vaccine research and development.
  • To highlight the efficacy and safety of various vaccine types, including synthetic carbohydrate antigen vaccines.
  • To explore the potential integration of cancer vaccines into clinical practice and their impact on pharmacy services.

Main Methods:

  • Review of ongoing and completed clinical trials (Phase II and III) for various cancer vaccines.
  • Analysis of systemic responses and toxicities associated with vaccine administration.
  • Examination of potential combination therapies involving cancer vaccines.

Main Results:

  • Many cancer vaccines demonstrate efficacy in eliciting systemic immune responses with acceptable toxicity profiles.
  • Phase III trials for melanoma and colon cancer vaccines have concluded, with promising Phase II results for synthetic carbohydrate antigen vaccines in multiple tumor types.
  • Vaccine therapy is being actively investigated as a fourth modality of cancer treatment.

Conclusions:

  • Cancer vaccines are nearing the stage of routine clinical use, offering a new therapeutic avenue.
  • The evolving role of pharmacists in patient counseling and potential direct dispensing of vaccines is highlighted.
  • The integration of cancer vaccines into standard care is anticipated in the near future, potentially transforming cancer treatment paradigms.

Related Experiment Videos